S. Silva, J. Duarte, C. Simão, and M. Felizardo, “Osimertinib: A Game-Changer in Stage IV EGFR-Driven Lung Cancer”, Acta Med Port, vol. 38, no. 9, pp. 568–572, Apr. 2025.